PURPOSE: This pilot exploratory study aimed to describe the changes in nutritional status, body composition, quality of life (QoL), and physical activity levels (PAL) of cancer patients undergoing high-dose conditioning and autologous peripheral blood stem cell transplantation (PBSCT) at pre-admission, hospital discharge, and at 100 days post-transplantation, and to examine if changes in these parameters are interrelated. METHODS: Twenty-four patients (56.2 ± 12.9 years; 7 females, 17 males) were recruited from an Australian transplant center. Assessment was prospectively conducted at pre-admission, hospital discharge, and 100 days post-transplantation using the scored patient-generated subjective global assessment, air displacement plethysmography, EORTC QLQ-C30 (version 3), and the international physical activity questionnaire. RESULTS: At discharge, nutritional status deteriorated (patient-generated subjective global assessment (PG-SGA) median, +8.0; interquartile range, 6.0-13.0; p < 0.001) and the number of malnourished patients increased (n = 8/23; p = 0.023). Patients experienced significant loss of lean body mass (LBM; -2.2 kg, CI 95% -3.0, -1.4; p < 0.001), and decrease in QoL (-10.6, CI 95% -24.1, 2.9; p = 0.117); the proportion of patients with high PAL decreased (p = 0.012). By 100 days post-transplantation, all patients were well-nourished; however, LBM remained lower -1.0 kg (CI 95% -1.9, -0.1; p = 0.028). Change in nutritional status (PG-SGA score) was associated with weight (r = -0.46; p = 0.039) and fat mass (r = -0.57; p = 0.013). Change in QoL was associated with nutritional reservoir (i.e., fat; r = 0.54; p = 0.024); QoL was consistently higher for patients with high PAL. CONCLUSIONS: High-dose conditioning and autologous PBSCT is associated with deterioration in nutritional status, QoL and PAL, with LBM remaining below baseline levels at 100 days post-transplantation. A nutrition and exercise intervention program post-hospital discharge may be beneficial for these patients.
PURPOSE: This pilot exploratory study aimed to describe the changes in nutritional status, body composition, quality of life (QoL), and physical activity levels (PAL) of cancerpatients undergoing high-dose conditioning and autologous peripheral blood stem cell transplantation (PBSCT) at pre-admission, hospital discharge, and at 100 days post-transplantation, and to examine if changes in these parameters are interrelated. METHODS: Twenty-four patients (56.2 ± 12.9 years; 7 females, 17 males) were recruited from an Australian transplant center. Assessment was prospectively conducted at pre-admission, hospital discharge, and 100 days post-transplantation using the scored patient-generated subjective global assessment, air displacement plethysmography, EORTC QLQ-C30 (version 3), and the international physical activity questionnaire. RESULTS: At discharge, nutritional status deteriorated (patient-generated subjective global assessment (PG-SGA) median, +8.0; interquartile range, 6.0-13.0; p < 0.001) and the number of malnourished patients increased (n = 8/23; p = 0.023). Patients experienced significant loss of lean body mass (LBM; -2.2 kg, CI 95% -3.0, -1.4; p < 0.001), and decrease in QoL (-10.6, CI 95% -24.1, 2.9; p = 0.117); the proportion of patients with high PAL decreased (p = 0.012). By 100 days post-transplantation, all patients were well-nourished; however, LBM remained lower -1.0 kg (CI 95% -1.9, -0.1; p = 0.028). Change in nutritional status (PG-SGA score) was associated with weight (r = -0.46; p = 0.039) and fat mass (r = -0.57; p = 0.013). Change in QoL was associated with nutritional reservoir (i.e., fat; r = 0.54; p = 0.024); QoL was consistently higher for patients with high PAL. CONCLUSIONS: High-dose conditioning and autologous PBSCT is associated with deterioration in nutritional status, QoL and PAL, with LBM remaining below baseline levels at 100 days post-transplantation. A nutrition and exercise intervention program post-hospital discharge may be beneficial for these patients.
Authors: Alois Gratwohl; Helen Baldomero; Mahmoud Aljurf; Marcelo C Pasquini; Luis Fernando Bouzas; Ayami Yoshimi; Jeff Szer; Jeff Lipton; Alvin Schwendener; Michael Gratwohl; Karl Frauendorfer; Dietger Niederwieser; Mary Horowitz; Yoshihisa Kodera Journal: JAMA Date: 2010-04-28 Impact factor: 56.272
Authors: A Olivieri; D Capelli; M Montanari; M Brunori; D Massidda; A Poloni; M Lucesole; R Centurioni; M Candela; M C Masia; C Tonnini; P Leoni Journal: Bone Marrow Transplant Date: 2001-06 Impact factor: 5.483
Authors: M Hadjibabaie; M Iravani; M Taghizadeh; A Ataie-Jafari; A R Shamshiri; S A Mousavi; K Alimoghaddam; S Hosseini; A Ghavamzadeh Journal: Bone Marrow Transplant Date: 2008-07-07 Impact factor: 5.483
Authors: Romina L Barritta de Defranchi; Andrea Bordalejo; Inés Cañueto; Angeles Villar; Elizabet Navarro Journal: Support Care Cancer Date: 2014-10-28 Impact factor: 3.603
Authors: Sophie Schur; Alexandra Ebert-Vogel; Michaela Amering; Eva Katharina Masel; Marie Neubauer; Andrea Schrott; Ingrid Sibitz; Herbert Watzke; Beate Schrank Journal: Support Care Cancer Date: 2014-05-09 Impact factor: 3.603
Authors: Petra G Puhringer; Alicia Olsen; Mike Climstein; Sally Sargeant; Lynnette M Jones; Justin W L Keogh Journal: PeerJ Date: 2015-11-10 Impact factor: 2.984
Authors: Tobias Rachow; Sebastian Dornaus; Herbert G Sayer; Beate Hermann; Andreas Hochhaus; Marie von Lilienfeld-Toal Journal: Clin Case Rep Date: 2016-04-12
Authors: Christina Ramsenthaler; Thomas R Osborne; Wei Gao; Richard J Siegert; Polly M Edmonds; Stephen A Schey; Irene J Higginson Journal: BMC Cancer Date: 2016-07-07 Impact factor: 4.430